Novo Nordisk rebounds
In a statement, Trotter described his experience as a child with older relatives who struggled with Type 2 diabetes. Trotter ...
Novo Nordisk said on Wednesday it would offer doses of its weight-loss drug Wegovy at a reduced cost of $499 per month for ...
Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much longer.
The Food and Drug Administration has declared an end to the shortage of Novo Nordisk’s blockbuster ... sold under the brand names Ozempic for diabetes and Wegovy for obesity, had been on the ...
The Food and Drug Administration on Friday said the shortage of Novo Nordisk's weight-loss and diabetes drugs Wegovy and Ozempic is resolved, a move that could limit the availability of cheaper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results